United States - English - NLM (National Library of Medicine)

alvix laboratories, llc - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h) - alternaria alternata 20000 [pnu] in 1 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

bio-rad laboratories pty ltd - ct929 - acquired genetic alteration ivds - ivds that are intended to be used in genetic testing to provide information about acquired genetic alterations, which may include chromosomal alterations, mutations and/or alterations in gene expression, and which may be used to characterise haematological or solid tumour malignancies and/or provide prognostic information.

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - etoricoxib - film coated tablet - 30 milligram - coxibs - antiinflammatory and antirheumatic products, non-steroids, coxibs - etoricoxib is indicated in adults and adolescents 16 years of age and older for the symptomatic relief of osteoarthritis (oa), rheumatoid arthritis (ra), ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis. etoricoxib is indicated in adults and adolescents 16 years of age and older for the short-term treatment of moderate pain associated with dental surgery. the decision to prescribe a selective cyclooxygenase-2 (cox-2) inhibitor should be based on an assessment of the individual patient's overall risks

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - etoricoxib - film coated tablet - 60 milligram - coxibs - antiinflammatory and antirheumatic products, non-steroids, coxibs - etoricoxib is indicated in adults and adolescents 16 years of age and older for the symptomatic relief of osteoarthritis (oa), rheumatoid arthritis (ra), ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis. etoricoxib is indicated in adults and adolescents 16 years of age and older for the short-term treatment of moderate pain associated with dental surgery. the decision to prescribe a selective cyclooxygenase-2 (cox-2) inhibitor should be based on an assessment of the individual patient's overall risks

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - etoricoxib - film coated tablet - 90 milligram - coxibs - antiinflammatory and antirheumatic products, non-steroids, coxibs - etoricoxib is indicated in adults and adolescents 16 years of age and older for the symptomatic relief of osteoarthritis (oa), rheumatoid arthritis (ra), ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis. etoricoxib is indicated in adults and adolescents 16 years of age and older for the short-term treatment of moderate pain associated with dental surgery. the decision to prescribe a selective cyclooxygenase-2 (cox-2) inhibitor should be based on an assessment of the individual patient's overall risks

Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - etoricoxib - film coated tablet - 120 milligram - coxibs - antiinflammatory and antirheumatic products, non-steroids, coxibs - etoricoxib is indicated in adults and adolescents 16 years of age and older for the symptomatic relief of osteoarthritis (oa), rheumatoid arthritis (ra), ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis. etoricoxib is indicated in adults and adolescents 16 years of age and older for the short-term treatment of moderate pain associated with dental surgery. the decision to prescribe a selective cyclooxygenase-2 (cox-2) inhibitor should be based on an assessment of the individual patient's overall risks

United States - English - NLM (National Library of Medicine)

antigen laboratories, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), ambrosia trifida pollen (unii: ku1v1898xx) (ambrosia trifida pollen - unii:ku1v1898xx), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), ambrosia psilostachya pollen (unii: rx18m46k8l) (ambrosia psilostachya pollen - unii:rx18m46k8l), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), carya alba pollen (unii: g2a764t54b - alternaria alternata 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

United States - English - NLM (National Library of Medicine)

antigen laboratories, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), felis catus hair (unii: 1564hd0n96) (felis catus hair - unii:1564hd0n96), canis lupus familiaris hair (unii: 05s7l91ztr) (canis lupus familiaris hair - unii:05s7l91ztr), phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense pollen - unii:65m88rw2eg) - alternaria alternata 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

United States - English - NLM (National Library of Medicine)

antigen laboratories, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), cochliobolus sativus (unii: 3ln5b70u4w) (cochliobolus sativus - unii:3ln5b70u4w), cladosporium cladosporioides (unii: 4zwy20gtgo) (cladosporium cladosporioides - unii:4zwy20gtgo), penicillium chrysogenum var. chrysogenum (unii: 3y1pe1gcig) (penicillium chrysogenum var. chrysogenum - unii:3y1pe1gcig) - alternaria alternata 0.01 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

Philippines - English - FDA (Food And Drug Administration)

scheele laboratories phils., inc. - drug - doxycycline (as hyclate) - doxalin